Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response - PubMed (original) (raw)
Review
Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response
Peter J Murray. Curr Opin Pharmacol. 2006 Aug.
Abstract
Interleukin (IL)-10 performs an irreplaceable role in negatively regulating inflammation, primarily through a mechanism that selectively blocks the expression of pro-inflammatory genes encoding cytokines, chemokines, cell-surface molecules and other molecules involved in the propagation of inflammation. Not surprisingly, IL-10 has attracted interest as a tool to regulate inflammatory diseases. The clinical use of IL-10 as an anti-inflammatory agent has, however, not met expectations. Nevertheless, the signaling pathway used by the IL-10 receptor to generate the anti-inflammatory response is only beginning to be understood and could be a way to regulate inflammation by pharmacological agents.
Similar articles
- STAT3-mediated anti-inflammatory signalling.
Murray PJ. Murray PJ. Biochem Soc Trans. 2006 Dec;34(Pt 6):1028-31. doi: 10.1042/BST0341028. Biochem Soc Trans. 2006. PMID: 17073743 - STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, Franchi L. Samavati L, et al. Mol Immunol. 2009 May;46(8-9):1867-77. doi: 10.1016/j.molimm.2009.02.018. Epub 2009 Mar 18. Mol Immunol. 2009. PMID: 19299019 - An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H, Minoda Y, Saeki K, Koga K, Takaesu G, Onodera M, Yoshimura A, Kobayashi T. Nishinakamura H, et al. Int Immunol. 2007 May;19(5):609-19. doi: 10.1093/intimm/dxm026. Epub 2007 Mar 22. Int Immunol. 2007. PMID: 17383969 - Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.
Harizi H, Gualde N. Harizi H, et al. Cell Mol Immunol. 2006 Aug;3(4):271-7. Cell Mol Immunol. 2006. PMID: 16978535 Review. - Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M. Mitsuyama K, et al. Anticancer Res. 2007 Nov-Dec;27(6A):3749-56. Anticancer Res. 2007. PMID: 17970038 Review.
Cited by
- The Enigmatic Interplay of Interleukin-10 in the Synergy of HIV Infection Comorbid with Preeclampsia.
Naidoo SJ, Naicker T. Naidoo SJ, et al. Int J Mol Sci. 2024 Aug 30;25(17):9434. doi: 10.3390/ijms25179434. Int J Mol Sci. 2024. PMID: 39273381 Free PMC article. Review. - Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.
Serradas ML, Ding Y, Martorell PV, Kulińska I, Castro-Gomez S. Serradas ML, et al. Cells. 2024 Aug 26;13(17):1426. doi: 10.3390/cells13171426. Cells. 2024. PMID: 39272998 Free PMC article. Review. - Targeting cytokine and chemokine signaling pathways for cancer therapy.
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. Yi M, et al. Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3. Signal Transduct Target Ther. 2024. PMID: 39034318 Free PMC article. Review. - Effects of interleukin-10 treated macrophages on bone marrow mesenchymal stem cells via signal transducer and activator of transcription 3 pathway.
Lyu MH, Bian C, Dou YP, Gao K, Xu JJ, Ma P. Lyu MH, et al. World J Stem Cells. 2024 May 26;16(5):560-574. doi: 10.4252/wjsc.v16.i5.560. World J Stem Cells. 2024. PMID: 38817327 Free PMC article. - IL-15 Complex-Induced IL-10 Enhances Plasmodium-specific CD4+ T Follicular Helper Differentiation and Antibody Production.
Bravo M, Dileepan T, Dolan M, Hildebrand J, Wolford J, Hanson ID, Hamilton SE, Frosch AE, Burrack KS. Bravo M, et al. J Immunol. 2024 Mar 15;212(6):992-1001. doi: 10.4049/jimmunol.2300525. J Immunol. 2024. PMID: 38305633
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous